Keyphrases
Adaptive Resistance
75%
Amikacin
100%
Bacterial Growth
25%
Bacterial Killing
25%
Bacterial Resistance
50%
Children with Cancer
25%
Clinical Data
25%
Curve Data
25%
Divided Dose
25%
Dosing Regimen
25%
Drug Resistance
25%
Dynamic Nature
25%
Index-based
25%
Low Dose Rate
25%
Measurement Error
25%
Once-daily
50%
Optimal Dosing Strategy
25%
PD Model
25%
Pediatric Cancer Patients
100%
Pediatric Patients
50%
Pharmacodynamics
25%
Pharmacokinetic Analysis
100%
Pharmacokinetic Simulation
25%
Pharmacokinetics-pharmacodynamics (PK-PD)
25%
PK Modeling
25%
Plasma Concentration
25%
Population Pharmacokinetic Model
25%
Population Probability
25%
Probability Approach
75%
Pseudomonas Aeruginosa (P. aeruginosa)
25%
Repeated Dosing
50%
Simulation Analysis
25%
Simulation Study
25%
Steady State
25%
Time-kill Curves
25%
Trough Plasma Concentration
25%
Twice a Day
25%
Pharmacology, Toxicology and Pharmaceutical Science
Amikacin
100%
Antibiotic Resistance
50%
Drug Resistance
25%
Malignant Neoplasm
100%
Pharmacodynamics
100%
Pharmacokinetics
100%
Pseudomonas aeruginosa
25%